BioSpace News Archive

MRI compatible cochlear implant is an electronic medical device, which is implanted in the ear to repair the function of the damaged ear.

Transparency Market Research has published a new report on the HIV/AIDS diagnostics market for the forecast period of 2019–2027.

Transparency Market Research has recently published a new research report that talks about the overall landscape of the global empty capsules market.

Evasc Neurovascular, a pioneer in the development of disruptive endovascular treatments for cerebral aneurysms, announced the enrollment of the first patient in its French eCLIPs™ Safety, Feasibility and Efficacy Study.

Traditionally, rapid characterisation of variants that cause genetic disease, from whole human genome sequencing, has been challenging.

Adagene Inc. announced that the first patients have been dosed in a phase 1b/2 clinical trial of the anti-CD137 agonist antibody, ADG106, in combination with the anti-PD-1 antibody, Nivolumab for patients with advanced non-small cell lung cancer who have progressed on prior therapies.

ITM Isotope Technologies Munich SE, a leading radiopharmaceutical biotech company, and Helmholtz Munich, announced a cooperation agreement for the clinical development of a radiopharmaceutical therapy candidate to treat malignant brain tumor glioblastoma.

Bioretec Ltd, a globally operating Finnish medical device company and a pioneer in bioresorbable orthopedic implants, has entered into a raw material supply agreement with Meotec GmbH, a German manufacturer of implantable materials.

Ascletis Pharma Inc. announces the dosing of the first patient in the Phase II clinical trial of ASC40 for moderate to severe acne.

Immuron Limited, an Australian biopharmaceutical company focused on developing and commercializing oral immunotherapeutics for the prevention and treatment of gut mediated pathogens, is pleased to announce that it has been granted a European Patent for compositions and methods for treating travelers’ diarrhea.